Examination Report |
1 | Additional Representation Sheet | 21 Feb 2012 |
10 | TM-R(RENEWAL OF TRADE MARK) | 21 Feb 2022 |
2 | TM-1 | 21 Feb 2012 |
3 | Authorization Document (POA) | 21 Feb 2012 |
4 | Correspondence | 21 Feb 2012 |
5 | Correspondence | 29 May 2013 |
6 | Reply to Exam Report (MIS-R) | 10 Aug 2017 |
7 | Hearing Notice | 08 Feb 2018 |
8 | Journal Copy | 13 Apr 2018 |
9 | Certificate | 06 Jul 2018 |
1 | Dispatching of Examination Report for : 2286518 | 1708229 | 990820 | 27 Nov 2014 |
2 | Hearing Notice (Show Cause) | 5649384 | 03 Jan 2018 | |
3 | Tribunal Accepted Notice for : 2286518 | 5862766 | 08 Feb 2018 | |
4 | O3 NOTICE | 12473221 | 5381027 | 15 Nov 2021 |
5 | RENEWAL INTIMATION LETTER | 13076747 | 25 Feb 2022 |
The application for Biofenib was made on 21 February 2012.
The trademark applicant for Biofenib is UNITED BIOTECH.
Biofenib is applied in class(es) 5.
Application for Biofenib is on Registered stage.
Application Id allotted to Biofenib is 2286518.
Trademark agent or attorney for the application is Sim & San Advocates.
Biofenib filed with the Intellectual property office as a WORD.